Classification as an orphan drug incentivizes and supports the development of certain treatments, increasing access to therapies for rare diseases and providing significant benefits, including...

To read the full story on AllPennyStocks.com, click here.

Nurexone Biologic (TSXV:NRX)
過去 株価チャート
から 5 2024 まで 6 2024 Nurexone Biologicのチャートをもっと見るにはこちらをクリック
Nurexone Biologic (TSXV:NRX)
過去 株価チャート
から 6 2023 まで 6 2024 Nurexone Biologicのチャートをもっと見るにはこちらをクリック